comparemela.com

Latest Breaking News On - Mechoulamr pharmacokinetics - Page 1 : comparemela.com

Innocan Pharma Corporation: Innocan Pharma Meets Pre-Clinical End-Point in Pilot Pain Study on Dogs Using LPT Liposome Technology

6 dogs suffering from osteoarthritis and lameness demonstrated CBD concentrations 6 weeks after a single injectionPain and well-being scores improved following treatmentHerzliya, Israel and Calgary, Alberta (Newsfile

Israel generalTel avivHebrew universitySamarskaya oblastMechoulamr pharmacokineticsIris bincovichChezy barenholzBi sky globalCompany or innocanHebrew university of jerusalemAlberta newsfile corpInnocan pharma corporationPharma corporationCentral nervous systemConsumer wellnessJoint venture

Innocan Pharma Corporation: Innocan Pharma Is Reaching Close to 100% CBD Bioavailability In a Dog Clinical Study For its Proprietary LPT CBD Liposomal Delivery Platform

First results from a study on dogs showed close to 100% bioavailability of CBD using Innocan's LPT technologyThis is compared to 6.5-20% bioavailability in humans when administered orallyHerzliya, Israel

Israel generalTel avivHebrew universitySamarskaya oblastMechoulamr pharmacokineticsIris bincovichChezy barenholzRoni kamhiBi sky globalCompany or innocanHebrew university of jerusalemAlberta newsfile corpInnocan pharma corporationPharma corporationChief operatingCentral nervous system

vimarsana © 2020. All Rights Reserved.